News & Updates
Filter by Specialty:

Testosterone therapy in women may lower risks of MACE, breast cancer
Women on testosterone therapy (TTh) show a lower risk of major adverse cardiac events (MACE) than matched controls, while postmenopausal women have a comparable MACE risk and a similar or significantly reduced risk of breast cancer on age-based subanalysis, reports a study.
Testosterone therapy in women may lower risks of MACE, breast cancer
04 Jun 2024
Men with premature ejaculation cope by having repeated sex in a day
Patients with premature ejaculation (PE) tend to engage in multiple turns of sexual intercourse within a single day in an attempt to compensate for their first unsatisfactory sexual encounter, suggests a study.
Men with premature ejaculation cope by having repeated sex in a day
03 Jun 2024
Legume intake reduces colorectal cancer risk
Eating legumes may help avert the development of colorectal cancer, according to a study that has found an inverse association between legume consumption and colorectal cancer risk.
Legume intake reduces colorectal cancer risk
03 Jun 2024
Tobacco smoke exposure early in life ups paediatric IBD risk
A Scandinavian population-based birth cohort study reveals that children who were exposed to tobacco smoke during their early childhood have an increased risk of developing inflammatory bowel disease (IBD) later in life.
Tobacco smoke exposure early in life ups paediatric IBD risk
03 Jun 2024
Which diet is perfect for Parkinson’s disease patients?
A dietary pattern intervention may offer some help in reducing the symptoms of Parkinson’s disease (PD), including both motor and nonmotor symptoms, reports a study.
Which diet is perfect for Parkinson’s disease patients?
02 Jun 2024
Low-dose aspirin for AMD prevention? ASPREE data show no benefit
Use of aspirin at 100 mg per day proved unsuccessful at reducing the incidence of age-related macular degeneration (AMD) in a large cohort of older healthy individuals, according to medium-term data from the AMD substudy of the Aspirin in Reducing Events in the Elderly (ASPREE) trial.